← All organizations

Guangzhou Panyu Central Hospital

Academic/Hospital

Also known as: Guangzhou Panyu Central Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Feb 28, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (24 distinct, 11 trials)

Phase 4 (14 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

capecitabine

Phase 2 (6 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

doxorubicin

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT06763666CollaboratorPhase 4Feb 28, 2025
NCT05196945CollaboratorPhase 4Mar 31, 2022
NCT05182463OfficialPhase 4Jan 8, 2022
NCT05182463Overall official - principal investigatorPhase 4Jan 8, 2022
NCT05044117CollaboratorPhase 3Oct 31, 2021
NCT05273944CollaboratorPhase 1Jul 28, 2021
NCT04517214CollaboratorPhase 2Sep 1, 2020
NCT04418648CollaboratorPhase 2Jun 1, 2020
NCT05404516CollaboratorPhase 2Jan 1, 2020
NCT02815423CollaboratorPhase 1/Phase 2Jan 1, 2017
NCT02980250CollaboratorPhase 4Nov 1, 2015
NCT02296047CollaboratorN/ADec 1, 2014

Details

Last known activity: Feb 28, 2025